Search results
-
-
Title
-
Biopsychosocial contexts influence adult cognitive functioning concurrently and longitudinally
-
Author
-
Bennett, Jeanette M., Payen, Ameante, Bateman, James R., Persin, Michael J.
-
Date Created
-
2024
-
Subjects--Topical
-
Cognition--Age factors, Aging
-
Description
-
Background: Cognitive aging is a complex process that impacts human behavior. Identifying the factors that preserve cognitive functioning is a public health priority, given that 20% of the US population will be at least 65 years old in the next de...
-
-
Title
-
Childhood ADHD, going beyond the brain : a meta-analysis on peripheral physiological markers of the heart and the gut
-
Author
-
Bennett, Jeanette M., Payen, Ameante, Chen, Michelle J., Carter, T. Grace, Kilmer, Ryan P.
-
Subjects--Topical
-
Attention-deficit hyperactivity disorder, Children
-
Description
-
Attention-Deficit/Hyperactivity Disorder (ADHD) is the most common neurodevelopmental disorder diagnosed in children. Questions regarding its increased diagnostic rates and pharmacological treatments in developing children have led to a more holis...
-
-
Title
-
Low-dose metformin as a monotherapy does not reduce non-small-cell lung cancer tumor burden in mice
-
Author
-
Marino, Joseph S., Stott Bond, Nicole L., Dréau, Didier, Marriott, Ian, Bennett, Jeanette M., Turner, Michael J., Arthur, Susan
-
Subjects--Topical
-
Lungs--Cancer, Musculoskeletal system
-
Description
-
Non-small-cell lung cancer (NSCLC) makes up 80–85% of lung cancer diagnoses. Lung cancer patients undergo surgical procedures, chemotherapy, and/or radiation. Chemotherapy and radiation can induce deleterious systemic side effects, particularly wi...
-
-
Title
-
Low-dose metformin treatment reduces in vitro growth of the LL/2 non-small cell lung cancer cell line
-
Author
-
Marino, Joseph S., Dreau, Didier, Marriott, Ian, Bennett, Jeanette M.
-
Date Created
-
2022
-
Subjects--Topical
-
Cancer cells, Lungs--Cancer
-
Description
-
Lung cancer maintains a relatively small survival rate (~19%) over a 5-year period and up to 80-85% of all lung cancer diagnoses are Non-Small Cell Lung Cancer (NSCLC). To determine whether metformin reduces non-small cell lung cancer (NSCLC) LL/2...